128 related articles for article (PubMed ID: 1558968)
1. Anticoagulant and fibrinolytic activities are promoted, not retarded, in vivo after thrombin generation in the presence of a monoclonal antibody that inhibits activation of protein C.
Taylor FB; Hoogendoorn H; Chang AC; Peer G; Nesheim ME; Catlett R; Stump DC; Giles AR
Blood; 1992 Apr; 79(7):1720-8. PubMed ID: 1558968
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.
Koshiar RL; Somajo S; Norström E; Dahlbäck B
PLoS One; 2014; 9(8):e104200. PubMed ID: 25136857
[TBL] [Abstract][Full Text] [Related]
3. Protein C.
Esmon CT
Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
Levi M; ten Cate H; Bauer KA; van der Poll T; Edgington TS; Büller HR; van Deventer SJ; Hack CE; ten Cate JW; Rosenberg RD
J Clin Invest; 1994 Jan; 93(1):114-20. PubMed ID: 8282778
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms that regulate the anticoagulant function of coagulation factor V.
Thorelli E
Scand J Clin Lab Invest Suppl; 1999; 229():19-26. PubMed ID: 10097286
[TBL] [Abstract][Full Text] [Related]
6. The fibrinolytic potential of the normal primate following the generation of thrombin in vivo.
Giles AR; Nesheim ME; Herring SW; Hoogendoorn H; Stump DC; Heldebrant CM
Thromb Haemost; 1990 Jun; 63(3):476-81. PubMed ID: 2402750
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor.
van 't Veer C; Golden NJ; Kalafatis M; Mann KG
J Biol Chem; 1997 Mar; 272(12):7983-94. PubMed ID: 9065469
[TBL] [Abstract][Full Text] [Related]
8. In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma.
Pieters J; Lindhout T; Hemker HC
Blood; 1989 Aug; 74(3):1021-4. PubMed ID: 2502206
[TBL] [Abstract][Full Text] [Related]
9. A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va.
Mesters RM; Heeb MJ; Griffin JH
Biochemistry; 1993 Nov; 32(47):12656-63. PubMed ID: 8251484
[TBL] [Abstract][Full Text] [Related]
10. Protein C and fibrinolysis: a link between coagulation and fibrinolysis.
de Fouw NJ; Haverkate F; Bertina RM
Adv Exp Med Biol; 1990; 281():235-43. PubMed ID: 2102614
[TBL] [Abstract][Full Text] [Related]
11. Thrombin-activated and factor Xa-activated human factor VIII: differences in cofactor activity and decay rate.
Neuenschwander PF; Jesty J
Arch Biochem Biophys; 1992 Aug; 296(2):426-34. PubMed ID: 1632634
[TBL] [Abstract][Full Text] [Related]
12. Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation.
Ni Ainle F; Preston RJ; Jenkins PV; Nel HJ; Johnson JA; Smith OP; White B; Fallon PG; O'Donnell JS
Blood; 2009 Aug; 114(8):1658-65. PubMed ID: 19531655
[TBL] [Abstract][Full Text] [Related]
13. Studies of Factors V and VIII:C in an animal model of disseminated intravascular coagulation.
Giles AR; Nesheim ME; Mann KG
J Clin Invest; 1984 Dec; 74(6):2219-25. PubMed ID: 6439744
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of human factor VII activation.
Butenas S; Mann KG
Biochemistry; 1996 Feb; 35(6):1904-10. PubMed ID: 8639673
[TBL] [Abstract][Full Text] [Related]
15. Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent cytoprotective functions.
Mosnier LO; Yang XV; Griffin JH
J Biol Chem; 2007 Nov; 282(45):33022-33. PubMed ID: 17872949
[TBL] [Abstract][Full Text] [Related]
16. Activation of protein C in vivo.
Comp PC; Jacocks RM; Ferrell GL; Esmon CT
J Clin Invest; 1982 Jul; 70(1):127-34. PubMed ID: 6177716
[TBL] [Abstract][Full Text] [Related]
17. Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C.
Nesheim ME; Canfield WM; Kisiel W; Mann KG
J Biol Chem; 1982 Feb; 257(3):1443-7. PubMed ID: 6895752
[TBL] [Abstract][Full Text] [Related]
18. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
[TBL] [Abstract][Full Text] [Related]
19. The light chain of factor Va contains the activity of factor Va that accelerates protein C activation by thrombin.
Salem HH; Broze GJ; Miletich JP; Majerus PW
J Biol Chem; 1983 Jul; 258(14):8531-4. PubMed ID: 6688078
[TBL] [Abstract][Full Text] [Related]
20. In vivo-generated thrombin and plasmin do not activate the complement system in baboons.
Keshari RS; Silasi R; Lupu C; Taylor FB; Lupu F
Blood; 2017 Dec; 130(24):2678-2681. PubMed ID: 29021229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
